UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Volatile biomarkers from human melanoma cells

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013-07, Vol.931, p.90-96

2013

Volltextzugriff (PDF)

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.851-861.e4

2016

Volltextzugriff (PDF)

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

Journal of investigative dermatology, 2005-11, Vol.125 (5), p.889-894

2005

Volltextzugriff (PDF)

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

Journal of the American Academy of Dermatology, 2012-05, Vol.66 (5), p.742-751

2012

Volltextzugriff (PDF)

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

Frontiers in immunology, 2024, Vol.15, p.1331217-1331217

2024

Volltextzugriff (PDF)

Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM

Journal of investigative dermatology, 2012-04, Vol.132 (4), p.1117-1124

2012

Volltextzugriff (PDF)

Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

The Journal of dermatological treatment, 2019-08, Vol.30 (6), p.534-539

2019

Volltextzugriff (PDF)

Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy

JID innovations, 2024-09, Vol.4 (5), p.100297, Article 100297

2024

Volltextzugriff (PDF)

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

Cancer biology & therapy, 2009-05, Vol.8 (10), p.907-916

2009

Volltextzugriff (PDF)

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria

Current drug metabolism, 2003-04, Vol.4 (2), p.151

2003

Volltextzugriff (PDF)

Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing

BMC medical genetics, 2017-02, Vol.18 (1), p.11-11, Article 11

2017

Volltextzugriff (PDF)

WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Journal of the American Academy of Dermatology, 2015-01

2015

Volltextzugriff (PDF)

Multiple eccrine poromas in the setting of total body irradiation and immunosuppression

Journal of the American Academy of Dermatology, 2006-08, Vol.55 (2), p.S46-S49

2006

Volltextzugriff (PDF)

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of drugs in dermatology, 2015-07, Vol.14 (7), p.706

2015

Volltextzugriff (PDF)

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

Journal of the American Academy of Dermatology, 2017-11, Vol.77 (5), p.845-854.e5

2017

Volltextzugriff (PDF)

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

JAMA dermatology (Chicago, Ill.), 2015-09, Vol.151 (9), p.961

2015

Volltextzugriff (PDF)

Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

Journal of the American Academy of Dermatology, 2021-01, Vol.84 (1), p.60-69

2021

Volltextzugriff (PDF)

Protection against Pemphigus Foliaceus by Desmoglein 3 in Neonates

The New England journal of medicine, 2000-07, Vol.343 (1), p.31-35

2000

Volltextzugriff (PDF)

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Blood, 2008-09, Vol.112 (6), p.2484-2488

2008

Volltextzugriff (PDF)

Acute Mixed-Lineage Leukemia t(4;11)(q21;q23) Generates an MLL-AF4 Fusion Product

Proceedings of the National Academy of Sciences - PNAS, 1993-08, Vol.90 (16), p.7884-7888

1993

Volltextzugriff (PDF)

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases

Advances in therapy, 2023-11, Vol.40 (11), p.5090-5101

2023

Volltextzugriff (PDF)

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

Journal of investigative dermatology, 2018-09, Vol.138 (9), p.1973-1981

2018

Volltextzugriff (PDF)

27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB128-AB128

2021

Volltextzugriff (PDF)

Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effort

Journal of the American Academy of Dermatology, 2022-02, Vol.86 (2), p.359-364

2022

Volltextzugriff (PDF)

P107 Gastrointestinal symptoms in US patients with moderate-severe psoriasis and psoriatic arthritis

The American journal of gastroenterology, 2019-07, Vol.114 (1), p.S28-S28

2019

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(31)
Dermatology
(21)
Female
(16)
Adult
(14)
Male
(14)
Middle Aged
(13)
Biological And Medical Sciences
(12)
Psoriasis
(11)
Medical Sciences
(10)
Severity Of Illness Index
(10)
Psoriasis - Drug Therapy
(9)
Aged
(8)
Animals
(7)
Registries
(7)
Ustekinumab
(6)
Biological Products - Therapeutic Use
(4)
Dose-Response Relationship, Drug
(4)
Follow-Up Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Volatile biomarkers from human melanoma cells

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM

Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy

Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues

Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria

Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing

WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Multiple eccrine poromas in the setting of total body irradiation and immunosuppression

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

Protection against Pemphigus Foliaceus by Desmoglein 3 in Neonates

Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-α receptor

Acute Mixed-Lineage Leukemia t(4;11)(q21;q23) Generates an MLL-AF4 Fusion Product

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effort

P107 Gastrointestinal symptoms in US patients with moderate-severe psoriasis and psoriatic arthritis

Suchergebnisse filtern